General info
Company name: | OÜ CENTRALPHARMA COMMUNICATIONS |
Name in transliteration: | OU CENTRALPHARMA COMMUNICATIONS |
Previous names: |
Osaühing Tsentraalfarmaatsia |
Registration code: | 10640025 |
VAT number: | EE100629860 |
Statistical code: | |
Legal status: | registered |
Address: | LESTA TN 26-11, HAABERSTI LINNAOSA, TALLINN, HARJU MAAKOND, 13522, EESTI |
Capital: | 40 000.00 EEK |
Activities: | EMTAK 2008: 70221 - Business and other management consultancy activities |
Legal form: | Limited liability company |
Date of registration: | 28.01.2000 |
Contacts
- +372 601****
- centralpharma@cent************
Log in or create an account to view full information.
Credit Opinion
Log in or create an account to view full information.
Turnover
Log in or create an account to view exact figures.
net profit
Log in or create an account to view exact figures.
Employees
Log in or create an account to view exact figures.
Managers
Role | Name | Code / Date of birth | Residence / location | Start date | Revision date |
---|---|---|---|---|---|
Member of the management board | KADRI K. | 46608****** | ******* | ********** |
Log in or create an account to view full information.
Beneficiaries
Name | Code / Date of birth | Residence / location | Share, % | Start date | Revision date |
---|---|---|---|---|---|
KADRI K. | *********** | ******* | ********** |
Log in or create an account to view full information.
Summary
- OÜ CENTRALPHARMA COMMUNICATIONS has been registered on 28.01.2000.
- The number of active managers in OÜ CENTRALPHARMA COMMUNICATIONS is 1.
- The number of active shareholders in OÜ CENTRALPHARMA COMMUNICATIONS is 1.
- The company has been operating in the market for 24 years and 2 months.
- The status of the company is registered.
- The company's activity is EMTAK 2008 - Business and other management consultancy activities.
- Share capital is 40 000.00 EEK.
- The company had 4 employees in 31.12.2022 year.
- The annual turnover of OÜ CENTRALPHARMA COMMUNICATIONS in 31.12.2022 was 1 153 895.00 EUR.
Order report forOÜ CENTRALPHARMA COMMUNICATIONS